Detection and Characterization of Antimicrobial Resistance
Detection and characterization of antimicrobial resistance is the area of diagnostic microbiology concerned with determining whether a microorganism is susceptible or resistant to antimicrobial agents and with identifying the mechanisms responsible. It spans phenotypic methods that measure growth in the presence of drug, targeted assays that flag specific resistance phenotypes, and molecular methods that detect the underlying resistance genes and mutations.
Definition
The systematic laboratory determination of an organism's response to antimicrobial agents and of the genetic and biochemical mechanisms underlying any reduced susceptibility, using phenotypic and molecular methods interpreted against standardized breakpoints.
Scope
This area orients the reader across three complementary approaches: standardized antimicrobial susceptibility testing that yields a susceptible-intermediate-resistant interpretation, phenotypic detection of clinically important resistance patterns such as beta-lactamase production, and molecular detection of resistance determinants. It frames how laboratories generate the susceptibility data used in patient care, surveillance, and stewardship, without offering treatment instructions.
Sub-topics
Core questions
- Is this organism susceptible or resistant to a given antimicrobial agent, and how is that judgement standardized?
- Which resistance phenotype is present, and what mechanism explains it?
- Which resistance genes or mutations are detectable, and how do genotype and phenotype relate?
Key concepts
- Minimum inhibitory concentration (MIC)
- Clinical breakpoints and S-I-R interpretation
- Phenotypic versus genotypic detection
- Beta-lactamase and carbapenemase production
- Acquired resistance genes and chromosomal mutations
- Genotype-phenotype concordance
- Standardization (CLSI, EUCAST)
Mechanisms
Phenotypic methods expose a standardized inoculum of the organism to defined antimicrobial concentrations and read growth inhibition, summarized as an MIC or zone diameter and interpreted against breakpoints set by standards bodies such as CLSI and EUCAST (jorgensen-2009; clsi-m100). Targeted phenotypic assays detect a specific resistance trait, for example the hydrolysis of a beta-lactam by a beta-lactamase. Molecular methods instead detect the genetic determinant directly, identifying acquired resistance genes or resistance-associated mutations; whole-genome sequencing increasingly allows comprehensive characterization, though genotype-phenotype prediction remains imperfect (ellington-2017). Expert rules encode known relationships between mechanisms and expected susceptibility to improve interpretation and flag inconsistent results (leclercq-2013).
Clinical relevance
Susceptibility and resistance characterization underpins the evidence used in infectious-disease management, antimicrobial stewardship, infection control, and resistance surveillance. As a reference area it describes how laboratories produce and interpret these data; it does not provide diagnostic or prescribing guidance for individual patients.
Epidemiology
Standardized susceptibility testing and resistance characterization generate the data feeding local antibiograms and national and international surveillance systems, which track the emergence and spread of resistant organisms and resistance mechanisms over time.
History
Antimicrobial susceptibility testing developed alongside the antibiotic era of the mid-twentieth century, with diffusion and dilution methods becoming standardized through bodies such as CLSI and EUCAST. Over subsequent decades the field added targeted phenotypic tests for emerging resistance mechanisms and, more recently, molecular and sequencing-based detection of resistance determinants (jorgensen-2009; ellington-2017).
Debates
- How far can genotype replace phenotype?
- Molecular and sequencing methods detect resistance determinants quickly but do not always predict the phenotype reliably; the extent to which genotypic prediction can substitute for phenotypic susceptibility testing remains an active question.
Related topics
Seminal works
- jorgensen-2009
- leclercq-2013
- ellington-2017
Frequently asked questions
- What is the difference between detecting resistance phenotypically and molecularly?
- Phenotypic methods observe whether the organism grows in the presence of a drug or expresses a specific resistance trait, while molecular methods detect the resistance gene or mutation directly; the two are complementary and do not always agree.
- Why are standardized breakpoints needed?
- Breakpoints from standards bodies such as CLSI and EUCAST translate a measured MIC or zone diameter into a susceptible, intermediate, or resistant category, so that results are comparable across laboratories.